(Yicai Global) Oct. 18 -- China Food and Drug Administration is asking provinces and municipalities across the country to report on the circulation of blood products as it gets a nationwide investigation underway.
Blood products are substances made from human blood and can include blood itself as well as the components that make it up, such as red blood cells.
The investigation has already begun, a purchaser at one blood product firm told the Economic Observer. The circulation of blood products is under intensive supervision due to the importance of the products and the potential for spreading diseases.
China began making blood products in the 1950s and the sector hit a growth spurt in the 1980s. The high profits available attracted many unqualified companies into the industry and led to a broad range of product quality, opening up potential health and safety risks.
Gross industrial output of blood products in China grew continuously from 2007 through 2016. The fastest-growing year of the period, 2011, saw CNY13.25 billion (USD2 billion) in output, up 43.5 percent on the year.